Literature DB >> 12604016

Cytokine and nitric oxide levels in a rat model of immunologic protection from adjuvant-induced arthritis.

A Conforti1, S Lussignoli, S Bertani, R Ortolani, L Cuzzolin, G Benoni, P Bellavite.   

Abstract

In the present study we investigated the correlation between the progression of adjuvant arthritis induced by Mycobacterium butyricum and the production of nitric oxide and some pro- and anti-inflammatory cytokines in arthritic rats and in rats treated with low intra-peritoneal doses of Mycobacterium 3 and 10 days after arthritis induction. The intra-peritoneal administration of Mycobacterium antigen significantly inhibited disease development. Compared to healthy rats, a rise in serum and peritoneal pro-inflammatory cytokines was observed in all arthritic rats already from the 14 day. The treatment with intra-peritoneal Mycobacterium was associated with a significant reduction in IL-6 serum concentrations and a slight decrease of IFN-gamma production by peritoneal macrophages. Nitrite/nitrate plasma and peritoneal levels were significantly higher in all arthritic rats. Intra-peritoneal administration of Mycobacterium caused a further increase in nitrite/nitrate plasma concentrations, while no differences were evident in nitric oxide production by peritoneal macrophages. From our data it is evident that among the variables here investigated, IL-6 seems to be the more representative marker of the disease and of the treatment effect. A possible role of nitric oxide as a modulator rather than a direct mediator in this model of inflammation is discussed.

Entities:  

Year:  2001        PMID: 12604016

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  3 in total

1.  Changes in Radixin Expression and Interaction with Efflux Transporters in the Liver of Adjuvant-Induced Arthritic Rats.

Authors:  Atsushi Kawase; Misaki Nakasaka; Hatsune Bando; Saori Yasuda; Hiroaki Shimada; Masahiro Iwaki
Journal:  Inflammation       Date:  2020-02       Impact factor: 4.092

2.  Immunology and homeopathy. 3. Experimental studies on animal models.

Authors:  Paolo Bellavite; Riccardo Ortolani; Anita Conforti
Journal:  Evid Based Complement Alternat Med       Date:  2006-05-02       Impact factor: 2.629

3.  Bone-Targeted Delivery of Novokinin as an Alternative Treatment Option for Rheumatoid Arthritis.

Authors:  Arina Ranjit; Sana Khajeh Pour; Ali Aghazadeh-Habashi
Journal:  Pharmaceutics       Date:  2022-08-12       Impact factor: 6.525

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.